1 Insight on

• No Human Health Outcome Reported

18 Insights on

• Improved Immune Function
• Enhanced Immune System Function
• Improved Immune Response
• Enhanced Immune Response
• Reduced Severity of Common Cold Symptoms
• Reduced Duration of Common Cold
• Enhanced Immune Function
• Reduced Fever Duration
• Increased CD4+ T Cell Count
• Increased CD8+ T Cells
• Reduced Symptom Severity
• Reduced Fever Duration During Common Cold
• Improved Cellular Immune Response
• Reduced Cold Symptoms
• Enhanced Immune Cell Activity
• Reduced Duration of Common Cold Episodes
• Improved T Helper Cell Count
• Enhanced Cytotoxic T Suppressor Cells (CD8+)

2 Insights on

• Reduced Risk of Bacterial Vaginosis
• Reduced Prevalence of Bacterial Vaginosis

6 Insights on

• Increased Lactobacillus Population
• Improved Gut Homeostasis
• Increased Population of Clostridium Histolyticum
• Reduced Population of Fusobacterium prausnitzii
• Increased Abundance of Bifidobacterium
• Maintained Gut Microbiome Homeostasis

3 Insights on

• Increased PMN Cell Phagocytic Capacity
• Enhanced Natural Killer Cell Tumoricidal Activity
• Reduced Myeloperoxidase Levels

18 Insights on

• Improved Immune Response
• Enhanced Immune Response
• Increased Serum Immunoglobulin A (IgA) Levels
• Improved Respiratory Infection Resistance
• Reduced Lung Damage
• Improved Immune Cell Function
• Enhanced Antipneumococcal IgA Levels in BAL
• Accelerated Innate Immune Response Recovery
• Improved Pathogen Clearance
• Improved Innate Immune Response
• Improved Bactericidal Function of Phagocytic Cells
• Elevated Antipneumococcal IgA Levels in Bronchoalveolar Lavage Fluid
• Enhanced Resistance to Streptococcus Pneumoniae Infection
• Improved Resistance to Pneumococcal Respiratory Infection
• Improved Immune Mechanisms Against S. pneumoniae
• Improved Pathogen Clearance from Blood
• Improved Immune Cell Counts
• Improved Resistance to Pneumococcal Infection

1 Insight on

• Reduced Antibiotic-Associated Diarrhea

3 Insights on

• Absence of Harmful Enzymatic Activities
• Maintained Normal Intestinal Microbiota
• Reduced Antibiotic Sensitivity

6 Insights on

• Reduced Giardia intestinalis Infection
• Reduced Fecal Shedding of Giardia Antigens
• Reduced Parasite-Induced Mucosal Damage
• Increased Cellular Response to Giardia Antigens
• Resolution of Giardia Infection
• Reduced Mucosal Damage

2 Insights on

• Improved Nasal Symptoms in Perennial Allergic Rhinitis
• Improved Ocular Symptoms

3 Insights on

• Endothelial Cell Damage
• Increased Tissue Necrosis
• Incidence of Thrombosis

5 Insights on

• Reduced Colitis Severity
• Increased Colonic Mucosa Adhesion
• Restored Protective Effect in Colitis
• Enhanced Colonic Mucosa Adhesion
• Restored Aggregation Phenotype and Protective Effect on Colitis

6 Insights on

• Reduced Triglyceride Levels
• Reduced Serum Triglyceride Levels
• Reduced Serum Homocysteine Levels
• Reduced Indoxyl Sulfate Levels
• Increased Folate Levels
• Reduced Pre-Dialysis Serum Triglyceride Levels

3 Insights on

• Reduced Concomitant Medication Usage
• Reduced Ocular Symptoms of Japanese Cedar Pollinosis
• Improved Distress of Life Score

7 Insights on

• Reduced T Cell Responsiveness
• Enhanced Dendritic Cell-T Cell Interaction
• Modulated Dendritic Cell Function
• Beneficial Clinical Effects
• Reduced T Cell Proliferation
• Reduced Th2 Cytokine Production
• Decreased Peripheral T Cell Response

3 Insights on

• Increased Lactobacilli Levels
• Increased Plasma Daidzein Levels
• Reduced Plasma Equol Concentration

8 Insights on

• Increased Fecal Bifidobacteria Levels
• Increased Fecal Bifidobacterium breve Levels
• Increased Bifidobacterial Population
• Enhanced Intestinal Antibody Response to Poliovirus Vaccination
• Increased Antipoliovirus IgA Levels
• Enhanced Immune Response to Poliovirus Vaccine
• Enhanced IgA Response
• Enhanced Antipoliovirus IgA Response

2 Insights on

• Increased Butyrate Production
• Reduced Lactate Accumulation

9 Insights on

• Reduced Muscle Hypercontractility
• Reduced Transforming Growth Factor Beta Levels
• Reduced Salivary Prostaglandin E2 Levels
• Improved Postinfective IBS Symptoms
• Modulated Immunologic Response
• Reduced Th2 Response
• Reduced Cyclooxygenase-2 Levels
• Reduced Postinfective Symptoms
• Improved Muscle Hypercontractility Post Infection

2 Insights on

• Reduced Salivary Levels of Mutans Streptococci
• Reduced Oral Carriage of Mutans Streptococci

2 Insights on

• Reduced Body Weight Gain
• Improved Serum KLH-specific IgA Levels

3 Insights on

• Protection Against Lethal STEC Infection
• Reduced Stx Production
• Increased Acetic Acid Production

5 Insights on

• Reduced Helicobacter pylori Colonization
• Reduced Gastric Ornithine Decarboxylase Activity
• Reduced Polyamine Levels
• Reduced Gastric Polyamine Levels
• Reduced Intragastric Bacterial Load

5 Insights on

• Reduced Duration of Diarrhea
• Reduced Diarrhea Incidence
• Reduced Acute Diarrhea Incidence
• Reduced Duration of Diarrhea Episodes
• Delayed Onset of First Diarrhea Episode

1 Insight on

• Reduced Risk of Chorioamnionitis

8 Insights on

• Reduced Gastric Mucosal Histiocyte Numbers
• Increased Duodenal B-Lymphocyte Counts
• Increased CD4-Positive T-Lymphocytes in Ileal Epithelium
• Increased Probiotic Bacteria Colonization
• Increased CD4-Positive T-Lymphocytes
• Gastrointestinal Tract Colonization
• Reduced Gastric Mucosal Histiocytes
• Increased Gastrointestinal Tract Colonization

4 Insights on

• Reduced Antibiotic Usage
• Improved Safe Consumption Practices
• Achieved Adequate Infant Growth
• Reduced Colic or Irritability

3 Insights on

• Reduced C-Reactive Protein Levels
• Increased Mortality Rate
• Increased C-Reactive Protein Levels

1 Insight on

• Increased Risk of Opportunistic Pathogenicity

3 Insights on

• Increased Antimicrobial Resistance
• Reduced Hospital-acquired Infections
• Increased Antibiotic-Resistant Enterococcal Dissemination